AAAAAA

   
Results: 1-9 |
Results: 9
Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro
Authors: Sakuma, S Kato, Y Nishigaki, F Magari, K Miyata, S Ohkubo, Y Goto, T
Citation: S. Sakuma et al., Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro, INT IMMUNO, 1(4), 2001, pp. 749-757
Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity
Authors: Tsujimoto, S Kawamura, I Inami, M Lacey, E Nishigaki, F Naoe, Y Manda, T Goto, T
Citation: S. Tsujimoto et al., Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity, ANTICANC R, 20(5A), 2000, pp. 3111-3116
FK506 potently inhibits T cell activation induced TNF-alpha and IL-1 beta production in vitvo by human peripheral blood mononuclear cells
Authors: Sakuma, S Kato, Y Nishigaki, F Sasakawa, T Magari, K Miyata, S Ohkubo, Y Goto, T
Citation: S. Sakuma et al., FK506 potently inhibits T cell activation induced TNF-alpha and IL-1 beta production in vitvo by human peripheral blood mononuclear cells, BR J PHARM, 130(7), 2000, pp. 1655-1663
Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI
Authors: Kawamura, I Lacey, E Inami, M Nishigaki, F Naoe, Y Tsujimoto, S Manda, T Goto, T
Citation: I. Kawamura et al., Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI, ANTICANC R, 19(5B), 1999, pp. 4091-4097
Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice
Authors: Kawamura, I Lacey, E Yamamoto, N Sakai, F Takeshita, S Inami, M Nishigaki, F Naoe, Y Tsujimoto, S Manda, T Shimomura, K Goto, T
Citation: I. Kawamura et al., Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice, ANTICANC R, 19(5B), 1999, pp. 4105-4111
Effects of a novel pyridylsulphonyl thiazole derivative, FR115092, on autoimmune and mitomycin C-induced thrombycytopenia in mice
Authors: Nishigaki, F Tsujimoto, S Inami, M Matsumoto, S Naoe, Y Kawamura, I Manda, T Shimomura, K
Citation: F. Nishigaki et al., Effects of a novel pyridylsulphonyl thiazole derivative, FR115092, on autoimmune and mitomycin C-induced thrombycytopenia in mice, J PHARM PHA, 51(7), 1999, pp. 857-865
FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice
Authors: Naoe, Y Inami, M Matsumoto, S Takagaki, S Fujiwara, T Yamazaki, S Kawamura, I Nishigaki, F Tsujimoto, S Manda, T Shimomura, K
Citation: Y. Naoe et al., FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice, JPN J CANC, 89(12), 1998, pp. 1306-1317
Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice
Authors: Naoe, Y Kawamura, I Inami, M Matsumoto, S Nishigaki, F Tsujimoto, S Manda, T Shimomura, K
Citation: Y. Naoe et al., Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice, JPN J CANC, 89(12), 1998, pp. 1318-1325
Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro
Authors: Naoe, Y Inami, M Takagaki, S Matsumoto, S Kawamura, I Nishigaki, F Tsujimoto, S Manda, T Shimomura, K
Citation: Y. Naoe et al., Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro, JPN J CANC, 89(10), 1998, pp. 1047-1054
Risultati: 1-9 |